Furthermore, these data support a role for exploiting the antigenic seniority model for development of a maternal HIV vaccine regimen, in which a universal heterologous HIV Env vaccine administered in the setting of infection and ART can boost maternal autologous virus-directed antibody responses. The gene discussed is ERVW-1; the disease is infection.